Literature DB >> 3877253

Brain metabolism as measured with positron emission tomography: serial assessment in a patient with familial Alzheimer's disease.

N R Cutler, J V Haxby, R Duara, C L Grady, A M Moore, J E Parisi, J White, L Heston, R M Margolin, S I Rapoport.   

Abstract

This paper presents, for the first time, repeated assessments of cerebral metabolism and neuropsychological competence in early Alzheimer's disease. Regional cerebral metabolic rates for glucose were measured with positron emission tomography and 18F-fluoro-2-deoxy-D-glucose on three occasions at 8-month intervals, in a 57-year-old man with Alzheimer's disease of 2 1/2 years' duration and with a family history of neuropathologically confirmed Alzheimer's disease. Data were compared with mean cerebral metabolic rates from 12 healthy men. No differences in regional cerebral metabolic rates for glucose were found on the initial patient scan, whereas metabolism on the second and third scans was reduced significantly in the parietal lobes and bilaterally in some parietal lobe regions. Memory loss was demonstrable at the first scan, but then and at later scans, other aspects of cognitive performance remained within normal limits (Wechsler Adult Intelligence Scale, Boston Naming Test, Two-dimensional Block Construction). The results show that memory loss can precede a measurable reduction of cerebral metabolism in early Alzheimer's disease, but that later reductions in parietal lobe metabolism may not be accompanied by additional measurable neuropsychological deficits.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3877253     DOI: 10.1212/wnl.35.11.1556

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  8 in total

Review 1.  Alzheimer's prevention initiative: a proposal to evaluate presymptomatic treatments as quickly as possible.

Authors:  Eric M Reiman; Jessica B S Langbaum; Pierre N Tariot
Journal:  Biomark Med       Date:  2010-02       Impact factor: 2.851

2.  The earliest cognitive change in a person with familial Alzheimer's disease: presymptomatic neuropsychological features in a pedigree with familial Alzheimer's disease confirmed at necropsy.

Authors:  S K Newman; E K Warrington; A M Kennedy; M N Rossor
Journal:  J Neurol Neurosurg Psychiatry       Date:  1994-08       Impact factor: 10.154

Review 3.  The role of clinical neuropsychology in the neurological diagnosis of Alzheimer's disease.

Authors:  H Spinnler; S Della Sala
Journal:  J Neurol       Date:  1988-05       Impact factor: 4.849

4.  Cerebral glucose utilization in pediatric neurological disorders determined by positron emission tomography.

Authors:  K Yanai; K Iinuma; T Matsuzawa; M Ito; S Miyabayashi; K Narisawa; T Ido; K Yamada; K Tada
Journal:  Eur J Nucl Med       Date:  1987

5.  Dominantly inherited Alzheimer's disease: cerebral glucose metabolism.

Authors:  R J Polinsky; H Noble; G Di Chiro; L E Nee; R G Feldman; R T Brown
Journal:  J Neurol Neurosurg Psychiatry       Date:  1987-06       Impact factor: 10.154

6.  Amyloid deposition begins in the striatum of presenilin-1 mutation carriers from two unrelated pedigrees.

Authors:  William E Klunk; Julie C Price; Chester A Mathis; Nicholas D Tsopelas; Brian J Lopresti; Scott K Ziolko; Wenzhu Bi; Jessica A Hoge; Ann D Cohen; Milos D Ikonomovic; Judith A Saxton; Beth E Snitz; Daniel A Pollen; Majaz Moonis; Carol F Lippa; Joan M Swearer; Keith A Johnson; Dorene M Rentz; Alan J Fischman; Howard J Aizenstein; Steven T DeKosky
Journal:  J Neurosci       Date:  2007-06-06       Impact factor: 6.167

7.  Verbal episodic memory and endogenous estradiol: an association in patients with mild cognitive impairment and Alzheimer's disease.

Authors:  D M Bittner; V Bittner; M W Riepe
Journal:  Curr Gerontol Geriatr Res       Date:  2011-12-19

8.  Brain Metabolism of Less-Educated Patients With Alzheimer Dementia Studied by Positron Emission Tomography.

Authors:  Yu Ching Huang; Pao Sheng Yen; Shwu Tzy Wu; Jung Tai Chen; Gung Uei Hung; Chia Hung Kao; Tai Yee Chen; Feng Ming Ho
Journal:  Medicine (Baltimore)       Date:  2015-07       Impact factor: 1.889

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.